Naltrexone Terminated Phase 4 Trials for Moderate-severe Pain / Moderate-severe Pain (All Types) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02680847Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain